Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

IOPAMIRO 300 INJECTION 6.12 G/10 ML [SIN05906P]

Active ingredients: IOPAMIRO 300 INJECTION 6.12 G/10 ML

View product's general information
Last updated 24 April 2026

Product Info

IOPAMIRO 300 INJECTION 6.12 G/10 ML

[SIN05906P]

Product information

Active Ingredient and Strength

IOPAMIDOL - 6.12 G/10 ML

Dosage Form

INJECTION

Manufacturer and Country

PATHEON ITALIA S.P.A - ITALY
BRACCO SPA - ITALY

Registration Number

SIN05906P

Licence Holder

DCH AURIGA SINGAPORE

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

V08AB04

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

INDICATIONS
NEURORADIOLOGY: myeloradiculography, cisternography and ventriculography.
ANGIOGRAPHY: cerebral arteriography, coronary arteriography, thoracic aortography, abdominal aortography, angiocardiography, selective visceral arteriography, peripheral arteriography, venography, digital subtraction angiography (DSA), DSA of cerebral arteries, DSA of peripheral arteries, DSA of abdominal arteries.
UROGRAPHY: intravenous urography.
CONTRAST ENHANCEMENT IN CT SCANNING. ARTHROGRAPHY. FISTULOGRAPHY.

Dosing

NEURORADIOLOGY

Iopamiro Dosage Table 1



ANGIOGRAPHY

Iopamiro Dosage Table 2



UROGRAPHY
Iopamiro 300 and 370 should be used; the dose recommended for this type of examination is 30 to 50 ml.
The less marked osmotic diuresis induced by the nonionic agent makes Iopamiro 370 especially suitable for patients with mild or moderately severe renal insufficiency and for neonates. The new contrast medium affords diagnostically useful nephrography even in patients with major renal insufficiency.

OTHER DIAGNOSTIC PROCEDURES

Iopamiro Dosage Table 3



For the enhancement of contrast in CT scans Iopamiro may be injected intravenously as a bolus, as a drip infusion or by a combination of the two methods.

Contraindications

CONTRAINDICATIONS
There are no definite or absolute contraindications to the use of Iopamiro, with the possible exception of Waldenström's macroglobulinemia, multiple myeloma, and severe liver and kidney diseases.